Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA

• Sam Gandy,
• David S. Knopman,
• Mary Sano

Affiliations

Sam Gandy

Department of Psychiatry, NIA-Designated Mount Sinai Alzheimer’s Disease Research Center

David S. Knopman

Department of Neurology, Mayo Clinic

Mary Sano

Department of Psychiatry, NIA-Designated Mount Sinai Alzheimer’s Disease Research Center